Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).

However, no consensus has yet been reached concerning the actual benefit of autologous stem cell transplantation (ASCT) in hepatitis B virus (HBV)- and/or hepatitis C virus (HCV)-positive patients, and data on patients with HBV and/or HCV infection following ASCT are very limited. HBV, hepatitis B virus infection; HCV, hepatitis C virus infections. gl In the subgroup analysis of HBV- or HCV-positive groups, histological types were not identified as independent prognostic factors; on the other hand, T-cell lymphoma patients without HBV and HCV infection showed worse survival (Fig S1). [Extracted from the article]